These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1211393)

  • 1. Letter: Volume control sets and incompatibilities.
    Jansen JR
    Am J Hosp Pharm; 1975 Dec; 32(12):1225. PubMed ID: 1211393
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous therapy. 4. The meaning of incompatibility; specific group incompatibilities.
    Williams JT; Moravec DF
    Hosp Manage; 1966 Apr; 101(4):87-8. PubMed ID: 5907995
    [No Abstract]   [Full Text] [Related]  

  • 3. Some incompatibilities of intravenous admixtures.
    Fowler TJ
    Am J Hosp Pharm; 1967 Aug; 24(8):450-7. PubMed ID: 6075730
    [No Abstract]   [Full Text] [Related]  

  • 4. The geriatric nurse's role in intravenous incompatibilities.
    Kabat HF
    Geriatr Nurs (Minneap); 1968 Jul; 4(7):6-8. PubMed ID: 5187466
    [No Abstract]   [Full Text] [Related]  

  • 5. [Incompatibilities of antibiotics administered by venous infusion].
    Flouvat B; Lechat P
    Therapie; 1974; 29(3):337-56. PubMed ID: 4439354
    [No Abstract]   [Full Text] [Related]  

  • 6. Problems in a bottle: the incompatibilities of drugs in parenteral solutions.
    Burgee SL
    Md Nurs News; 1968; 36(2):4-10. PubMed ID: 5187661
    [No Abstract]   [Full Text] [Related]  

  • 7. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
    Trissel LA; Chandler SW; Folstad JT
    Am J Hosp Pharm; 1990 Nov; 47(11):2525-8. PubMed ID: 2278268
    [No Abstract]   [Full Text] [Related]  

  • 8. The nurses role in intravenous incompatibilities.
    Price EM
    Minn Nurs Accent; 1968 Sep; 40(5):119-20 passim. PubMed ID: 4300083
    [No Abstract]   [Full Text] [Related]  

  • 9. LETTER: Safety of various intravenous solution systems.
    Wood WA
    Am J Hosp Pharm; 1975 Apr; 32(4):359. PubMed ID: 1130406
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of drug-use review principles to intravenous administration set use: a preliminary study.
    Rinehart JR; Wiederholt JB; Thielke TS
    Am J Hosp Pharm; 1986 Dec; 43(12):2998-3002. PubMed ID: 3812506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug incompatibility from the standpoint of the intravenous route of drug administration.
    Williams JT
    Hosp Manage; 1968 Jan; 105(1):38 passim. PubMed ID: 5634868
    [No Abstract]   [Full Text] [Related]  

  • 12. Blocking i.v. drug incompatibilities.
    Trissel LA
    Nursing; 1993 Jun; 23(6):74. PubMed ID: 8510845
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous solution manual and incompatibility file; its use in a community hospital.
    Donn R
    Am J Hosp Pharm; 1967 Aug; 24(8):459-61. PubMed ID: 6075731
    [No Abstract]   [Full Text] [Related]  

  • 14. [Physical and chemical incompatibilities of drug associations in syringes and perfusion bottles].
    Léopold G
    Anesth Analg (Paris); 1971; 28(5):879-86. PubMed ID: 5158891
    [No Abstract]   [Full Text] [Related]  

  • 15. The performance of intravenous drip sets.
    Hutchinson BR
    N Z Med J; 1969 Aug; 70(447):91-3. PubMed ID: 5258887
    [No Abstract]   [Full Text] [Related]  

  • 16. Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets.
    Trissel LA; Xu Q; Kwan J; Martinez JF
    Am J Hosp Pharm; 1994 Nov; 51(22):2804-10. PubMed ID: 7856604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physicochemical incompatibilities of injectable drugs].
    Hoffman M; Hazebroucq G
    Sem Hop; 1983 Feb; 59(8):541-7. PubMed ID: 6302899
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible incompatibilities with immune globulin for i.v. use.
    Hazlet TK; Tankersley DL
    Am J Hosp Pharm; 1993 Apr; 50(4):654, 659-60. PubMed ID: 8470675
    [No Abstract]   [Full Text] [Related]  

  • 19. Solution additive chemical incompatibility study.
    Parker EA
    Am J Hosp Pharm; 1967 Aug; 24(8):434-9. PubMed ID: 6075728
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of piggyback administration sets.
    Raisch DW; Johnson KT; Roth C
    Am J Hosp Pharm; 1977 Dec; 34(12):1315-23. PubMed ID: 596380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.